Invesco’s Upstream Bio Inc UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$370K Buy
53,397
+12,887
+32% +$108K ﹤0.01% 3368
2026
Q1
$365K Sell
40,510
-122,676
-75% -$2.21M ﹤0.01% 3270
2025
Q4
$4.43M Buy
163,186
+145,996
+849% +$3.63M ﹤0.01% 2298
2025
Q3
$323K Buy
17,190
+890
+5% +$13.8K ﹤0.01% 3390
2025
Q2
$179K Buy
16,300
+985
+6% +$9.1K ﹤0.01% 3541
2025
Q1
$93.7K Sell
15,315
-287
-2% -$2.74K ﹤0.01% 3631
2024
Q4
$256K Buy
+15,602
New +$348K ﹤0.01% 3461

Other funds holding UPB

Invesco's UPB Position: Q2 2026 in Review

Invesco increased its Upstream Bio Inc (UPB) stake by 32% in Q2 2026, buying an estimated $108K and bringing the position to 53,397 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #3368.

Invesco first reported a position in UPB in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.43M in Q4 2025. 149 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • Invesco held 53,397 shares of Upstream Bio Inc worth $370K as of Q2 2026.
  • Invesco bought 12,887 Upstream Bio Inc shares in Q2 2026, an estimated $108K.
  • Upstream Bio Inc made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3368 holding.
  • Invesco first reported a position in Upstream Bio Inc in Q4 2024 and has held it in 7 quarters since.
  • Invesco's Upstream Bio Inc position peaked at $4.43M in Q4 2025.
  • 149 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.